CDEK by Data4ThePeople
Sign in Sign up
← All organizations

Paladin Labs

For profitContributed to NME

Also known as: Paladin Laboratories Inc | Paladin Labs Inc.

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 4

First clinical trial

Mar 1, 2010

Last known activity

Jan 1, 2023

Acquired by Endo Pharmaceuticals → Mallinckrodt (2013) on Feb 26, 2014

Timeline

1980s

  1. Jan 1, 1983

    Paladin Labs— Founded

2000s

  1. Jan 1, 2008

    VIRexx— Acquired

2010s

  1. Jan 1, 2011

    Labopharm— Acquired

  2. Jul 16, 2013

    Allon Therapeutics— Acquired

  3. Feb 26, 2014

    Endo Pharmaceuticals— Acquired By

2020s

  1. Mar 1, 2025

    Mallinckrodt (2013)— Now

Drugs by trial phase (9 distinct, 27 trials)

Phase 4 (1 own, 0 via acquisition)

Phase 3 (1 own, 4 via acquisition)

Phase 2 (3 own, 0 via acquisition)

Indications

Studied for

Subsidiaries (3 direct, 3 total across the full acquisition tree)

Recent trials (4)

Details

Founded
Montreal, Quebec, CA Jan 1, 1983
Last known activity
Jan 1, 2023